Zhang Financial’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290K | Buy |
17,300
+100
| +0.6% | +$1.68K | 0.01% | 250 |
|
|
2025
Q1 | $264K | Buy |
17,200
+2,000
| +13% | +$30.7K | 0.01% | 258 |
|
|
2024
Q4 | $335K | Sell |
15,200
-900
| -6% | -$19.8K | 0.02% | 230 |
|
|
2024
Q3 | $290K | Sell |
16,100
-2,900
| -15% | -$52.3K | 0.02% | 230 |
|
|
2024
Q2 | $309K | Sell |
19,000
-7,000
| -27% | -$114K | 0.02% | 221 |
|
|
2024
Q1 | $367K | Hold |
26,000
| – | – | 0.03% | 209 |
|
|
2023
Q4 | $271K | Hold |
26,000
| – | – | 0.02% | 226 |
|
|
2023
Q3 | $265K | Buy |
26,000
+3,150
| +14% | +$32.1K | 0.03% | 208 |
|
|
2023
Q2 | $172K | Buy |
22,850
+1,900
| +9% | +$14.3K | 0.02% | 241 |
|
|
2023
Q1 | $185K | Hold |
20,950
| – | – | 0.02% | 225 |
|
|
2022
Q4 | $191K | Sell |
20,950
-1,000
| -5% | -$9.12K | 0.02% | 222 |
|
|
2022
Q3 | $177K | Buy |
21,950
+950
| +5% | +$7.66K | 0.03% | 209 |
|
|
2022
Q2 | $158K | Hold |
21,000
| – | – | 0.03% | 210 |
|
|
2022
Q1 | $197K | Buy |
21,000
+500
| +2% | +$4.69K | 0.03% | 211 |
|
|
2021
Q4 | $164K | Buy |
20,500
+3,200
| +18% | +$25.6K | 0.03% | 201 |
|
|
2021
Q3 | $169K | Buy |
17,300
+2,300
| +15% | +$22.5K | 0.04% | 159 |
|
|
2021
Q2 | $149K | Buy |
15,000
+1,500
| +11% | +$14.9K | 0.04% | 143 |
|
|
2021
Q1 | $156K | Buy |
+13,500
| New | +$156K | 0.04% | 128 |
|